Novel transcription coactivator complex containing activating signal cointegrator 1

Area of Science:

• Molecular Biology
• Gene Regulation
• Cellular Signaling

Background:

• Human activating signal cointegrator 1 (hASC-1) was initially identified as a transcriptional coactivator for nuclear receptors.
• The precise in vivo function and complex formation of hASC-1 remained incompletely understood.

Purpose of the Study:

• To elucidate the role of the endogenous hASC-1 complex in transcriptional regulation.
• To investigate the interaction of hASC-1 with other transcription factors and its effect on transrepression.

Main Methods:

• Characterization of the hASC-1 complex in HeLa nuclei.
• Analysis of hASC-1's binding interactions with transcription factors like SRF, AP-1, and NF-kappaB.
• Ectopic expression of Caenorhabditis elegans ASC-1 (ceASC-1) to assess dominant-negative effects.
• Microinjection of P50 antibodies to study the role of P50 in AP-1 transactivation.

Main Results:

• The hASC-1 complex, comprising P200, P100, and P50, directly binds and stimulates SRF, AP-1, and NF-kappaB.
• hASC-1 resolves transrepression between nuclear receptors and AP-1 or NF-kappaB.
• Ectopic ceASC-1 interferes with endogenous hASC-1 function, inhibiting AP-1, NF-kappaB, and SRF activity.
• P50 is essential for AP-1 transactivation, interacting with P200.

Conclusions:

• The endogenous hASC-1 complex is vital for the transactivation of AP-1, SRF, and NF-kappaB.
• hASC-1 mediates the transrepression between nuclear receptors and AP-1 or NF-kappaB in vivo.
• The P50 subunit, through interaction with P200, plays a critical role in hASC-1 complex function.